BIOMAT Database Logo BIOMAT Database Logo

Evaluating a national dissemination approach: The National Cancer Institute's clinical trials education program. 2009

Felicia M Solomon, and Sona Thakkar, and Allison Zambon, and Daniel S Eckstein, and Margo Michaels, and Lenora Johnson, and Linda Squiers
Office of Communications and Education, National Cancer Institute, NIH/DHHS, Bethesda, MD 20892, USA. solomonf@mail.nih.gov

BACKGROUND Adult participation in clinical trials is low, and many individuals are unaware of trials as an option. Raising awareness about clinical trials and addressing barriers through education is key to increasing enrollment in trials. METHODS To reach communities, the National Cancer Institute (NCI) worked with partners to disseminate clinical trials education resources. Evaluation was conducted to determine the effectiveness of the dissemination approaches on program goals. RESULTS Survey results indicated that partners disseminated, used, and were satisfied with the program resources. Focus group results corroborated these findings. CONCLUSIONS NCI's program successfully used partnerships for broad dissemination of resources to improve clinical trials awareness.

UI MeSH Term Description Entries
D007722 Health Knowledge, Attitudes, Practice Knowledge, attitudes, and associated behaviors which pertain to health-related topics such as PATHOLOGIC PROCESSES or diseases, their prevention, and treatment. This term refers to non-health workers and health workers (HEALTH PERSONNEL). Knowledge, Attitudes, Practice
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006266 Health Education Education that increases the awareness and favorably influences the attitudes and knowledge relating to the improvement of health on a personal or community basis. Community Health Education,Education, Health,Education, Community Health,Health Education, Community
D006306 Health Surveys A systematic collection of factual data pertaining to health and disease in a human population within a given geographic area. Abortion Surveys,Abortion Survey,Health Survey,Survey, Abortion,Survey, Health,Surveys, Abortion,Surveys, Health
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014481 United States A country in NORTH AMERICA between CANADA and MEXICO.
D015397 Program Evaluation Studies designed to assess the efficacy of programs. They may include the evaluation of cost-effectiveness, the extent to which objectives are met, or impact. Evaluation, Program,Family Planning Program Evaluation,Program Appropriateness,Program Effectiveness,Program Sustainability,Appropriateness, Program,Effectiveness, Program,Evaluations, Program,Program Evaluations,Program Sustainabilities,Sustainabilities, Program,Sustainability, Program
D017144 Focus Groups A method of data collection and a QUALITATIVE RESEARCH tool in which a small group of individuals are brought together and allowed to interact in a discussion of their opinions about topics, issues, or questions. Focus Group,Group, Focus,Groups, Focus
D054547 National Cancer Institute (U.S.) Component of the NATIONAL INSTITUTES OF HEALTH. Through basic and clinical biomedical research and training, it conducts and supports research with the objective of cancer prevention, early stage identification and elimination. This Institute was established in 1937. NCI (US),National Cancer Institute

Related Publications

Felicia M Solomon, and Sona Thakkar, and Allison Zambon, and Daniel S Eckstein, and Margo Michaels, and Lenora Johnson, and Linda Squiers
Update on the National Cancer Institute's clinical trials cooperative group program.
November 2004, Journal of the American College of Radiology : JACR,
Felicia M Solomon, and Sona Thakkar, and Allison Zambon, and Daniel S Eckstein, and Margo Michaels, and Lenora Johnson, and Linda Squiers
The National Cancer Institute's Clinical Trials Innovation Unit.
December 2023, Clinical advances in hematology & oncology : H&O,
Felicia M Solomon, and Sona Thakkar, and Allison Zambon, and Daniel S Eckstein, and Margo Michaels, and Lenora Johnson, and Linda Squiers
The National Cancer Institute's Cancer Education (R25E) Grants Program: an update.
January 2005, Journal of cancer education : the official journal of the American Association for Cancer Education,
Felicia M Solomon, and Sona Thakkar, and Allison Zambon, and Daniel S Eckstein, and Margo Michaels, and Lenora Johnson, and Linda Squiers
Why providers participate in clinical trials: considering the National Cancer Institute's Community Clinical Oncology Program.
November 2012, Contemporary clinical trials,
Felicia M Solomon, and Sona Thakkar, and Allison Zambon, and Daniel S Eckstein, and Margo Michaels, and Lenora Johnson, and Linda Squiers
Evaluation of the National Cancer Institute's clinical trials booklet.
January 1993, Journal of the National Cancer Institute. Monographs,
Felicia M Solomon, and Sona Thakkar, and Allison Zambon, and Daniel S Eckstein, and Margo Michaels, and Lenora Johnson, and Linda Squiers
The National Cancer Institute's Experimental Therapeutics Clinical Trials Network.
March 2015, Clinical advances in hematology & oncology : H&O,
Felicia M Solomon, and Sona Thakkar, and Allison Zambon, and Daniel S Eckstein, and Margo Michaels, and Lenora Johnson, and Linda Squiers
Evaluating productivity in clinical research programs: the National Cancer Institute's (NCI) Community Clinical Oncology Program (CCOP).
December 1992, Journal of medical systems,
Felicia M Solomon, and Sona Thakkar, and Allison Zambon, and Daniel S Eckstein, and Margo Michaels, and Lenora Johnson, and Linda Squiers
The National Cancer Institute's intervention trials.
October 1988, Cancer,
Felicia M Solomon, and Sona Thakkar, and Allison Zambon, and Daniel S Eckstein, and Margo Michaels, and Lenora Johnson, and Linda Squiers
Cancer prevention and control within the National Cancer Institute's clinical trials network: lessons from the Community Clinical Oncology Program.
November 1993, Journal of the National Cancer Institute,
Felicia M Solomon, and Sona Thakkar, and Allison Zambon, and Daniel S Eckstein, and Margo Michaels, and Lenora Johnson, and Linda Squiers
The National Cancer Institute's Drug Development Program.
January 1985, Progress in clinical and biological research,
Copied contents to your clipboard!